87 related articles for article (PubMed ID: 591127)
1. In vitro assessment of immunocompetence in patients with malignant melanoma.
Golub SH; Rangel DM; Morton DL
Int J Cancer; 1977 Dec; 20(6):873-80. PubMed ID: 591127
[TBL] [Abstract][Full Text] [Related]
2. Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy.
Golub SH; Forsythe AB; Morton DL
Int J Cancer; 1977 Jan; 19(1):18-26. PubMed ID: 137880
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
Rangel DM; Golub SH; Morton DL
Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
Pritchard DJ; Ritts RE; Taylor WF; Miller GC
Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells.
Roenhorst HW; Beelen JM; Middeldorp JM; Schirm J; Tegzess AM; The TH
Clin Exp Immunol; 1985 Jul; 61(1):72-9. PubMed ID: 2994923
[TBL] [Abstract][Full Text] [Related]
6. Impaired lymphocyte proliferation in human acute pancreatitis.
Pezzilli R; Billi P; Beltrandi E; Casadei Maldini M; Mancini R
Digestion; 1997; 58(5):431-6. PubMed ID: 9383633
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin enhancement of immunocompetence in melanoma patients.
Tilden AB; Balch CM
Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
[TBL] [Abstract][Full Text] [Related]
8. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte multiplication in vitro induced by mitogens and antigens.
Haneberg B; Wesenberg F; Aarskog D
Scand J Immunol; 1978; 8(1):9-13. PubMed ID: 360370
[TBL] [Abstract][Full Text] [Related]
10. An examination of the immunology of cancer patients.
Cochran AJ; Mackie RM; Grant RM; Ross CE; Connell MD; Sandilands G; Whaley K; Hoyle DE; Jackson AM
Int J Cancer; 1976 Sep; 18(3):298-309. PubMed ID: 783052
[TBL] [Abstract][Full Text] [Related]
11. A correlation between serum immunosuppressive acidic protein and altered immunocompetence in patients with brain tumours.
Kikuchi K; Gotoh H; Kowada M
Acta Neurochir (Wien); 1990; 103(1-2):52-61. PubMed ID: 2360468
[TBL] [Abstract][Full Text] [Related]
12. The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens.
Dean JH; Connor R; Herberman RB; Silva J; McCoy JL; Oldham RK
Int J Cancer; 1977 Sep; 20(3):359-70. PubMed ID: 143457
[TBL] [Abstract][Full Text] [Related]
13. [In vitro lymphocyte immunoreactivity in sarcoidosis patients. Stimulation with Kveim antigens].
Tartaglino B; Albera C; Vietti Ramus G; Cesano L
Arch Sci Med (Torino); 1982; 139(2):183-6. PubMed ID: 7138284
[TBL] [Abstract][Full Text] [Related]
14. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of human lymphocyte proliferative responses in vitro by pyrimethamine.
Bygbjerg IC
Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):111-3. PubMed ID: 7293778
[TBL] [Abstract][Full Text] [Related]
16. [Decrease of mitogen stimulation of lymphocytes in rheumatoid arthritis].
Genth E; Kurze R; Nowak H; Franz K; Brude E; Hartl W
Z Rheumatol; 1977; 36(5-6):168-79. PubMed ID: 899297
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy.
Lui VK; Karpuchas J; Dent PB; McCulloch PB; Blajchman MA
Br J Cancer; 1975 Sep; 32(3):323-30. PubMed ID: 1233077
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of lymphocytes from rheumatoid arthritis patients by mitogens and IgG.
Sany J; Clot J
Allerg Immunol (Leipz); 1976; 22(2):147-58. PubMed ID: 136882
[TBL] [Abstract][Full Text] [Related]
19. Immunocompetence, immunodeficiency and prognosis in cancer.
Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte proliferation in response to exercise.
Nielsen HB; Pedersen BK
Eur J Appl Physiol Occup Physiol; 1997; 75(5):375-9. PubMed ID: 9189722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
